NEUROSCIENCE 润色咨询

NEUROSCIENCE

出版年份：1976 年文章数：13649 投稿命中率： 开通期刊会员，数据随心看

出版周期：Semimonthly 自引率：3.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2025-07-03 匿名用户

    稿约不接收MR

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-09-09 ms8000000836096445

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向：脑血管疾病
    经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-07-02 qy872002 来自江苏省

    投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2024-05-13 ms2000000216251923 来自青海省

    投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2020-04-30 14870ea3m19暂无昵称

    刚投过了两天就with editor，这个状态一般持续多久呀132****4660暂无昵称 2020-03-25 00:00:00 发表:
    神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了

    132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了

    4

    展开4条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2023-01-18 ms4000000943549811 来自福建省

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-10-14 ms9000002127937775

    偏重的研究方向：基础
    经验分享：胶质瘤的可以投稿这个么

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-09-18 ms2000000324878155

    偏重的研究方向：脑血管病;临床
    经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2022-04-21 ms4000001333571855

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享：比较专业的杂志，业余的不要选择。审稿很认真

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2271870, encodeId=c30a22e1870b2, content=稿约不接收MR, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=匿名用户, createdTime=Thu Jul 03 10:55:32 CST 2025, time=2025-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2224847, encodeId=bc57222484e27, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向：脑血管疾病<br>经验分享：老牌杂志了，现在2.9分，小类四区，还算三区杂志吗？还会不会降哦？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efa08398558, createdName=ms8000000836096445, createdTime=Mon Sep 09 15:43:16 CST 2024, time=2024-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212888, encodeId=a5612212888a6, content=投稿时让自己选择编辑，大家有经验嘛？有推荐的嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fe7e1380311, createdName=qy872002, createdTime=Tue Jul 02 23:33:04 CST 2024, time=2024-07-02, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2204500, encodeId=f94322045006a, content=投稿后，退回要求重新上传Ethical statement，是说明动物实验伦理委员会那些信息，还是要加上所以作者同意，数据可用性之类的呀？<br>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=00559283998, createdName=ms2000000216251923, createdTime=Mon May 13 17:31:29 CST 2024, time=2024-05-13, status=1, ipAttribution=青海省), GetPortalCommentsPageByObjectIdResponse(id=590007, encodeId=591e59000e85, content=刚投过了两天就with editor，这个状态一般持续多久呀<span class="quote">132****4660暂无昵称 2020-03-25 00:00:00 发表:<br>神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了</span>, beContent=132****4660暂无昵称 2020-03-25 00:00:00 发表: 神经影像方面的，初审2个月内返回，小修后接收，很快就网络出版了，杂志效率很高。杂志影像因子和分区还可以了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=73235295163, createdName=14870ea3m19暂无昵称, createdTime=Thu Apr 30 00:00:00 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2110710, encodeId=35c02110e10ed, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：有拒稿重投的情况吗，这种情况是被拒稿还是什么啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5ca96462331, createdName=ms4000000943549811, createdTime=Wed Jan 18 12:37:50 CST 2023, time=2023-01-18, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2093841, encodeId=55f320938414e, content=偏重的研究方向：基础<br>经验分享：胶质瘤的可以投稿这个么 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=142, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c0e08209194, createdName=ms9000002127937775, createdTime=Fri Oct 14 21:42:54 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1778553, encodeId=0b151e78553f1, content=偏重的研究方向：脑血管病;临床<br>经验分享：审了两个月然后看官网信息直接拒了，不给发邮件吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f4a6506409, createdName=ms2000000324878155, createdTime=Sun Sep 18 09:58:12 CST 2022, time=2022-09-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1213006, encodeId=c39612130069a, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享：比较专业的杂志，业余的不要选择。审稿很认真, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=73ba6166615, createdName=ms4000001333571855, createdTime=Thu Apr 21 00:01:40 CST 2022, time=2022-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095840, encodeId=31111095840ee, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=)]
    2021-12-28 Gym璨烨

    回复评审的意见和期刊编辑的意见有什么不同？

    1

    展开1条回复
共152条页码: 1/16页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分